Literature DB >> 30166221

Prognostic factors in esophageal cancer treated with curative intent.

Véronique Vendrely1, Vincent Launay2, Haythem Najah2, Denis Smith3, Denis Collet4, Caroline Gronnier5.   

Abstract

The overall prognosis of patients with esophageal cancer has improved in recent decades due to surgical and medical progress, but overall survival remains poor. Better patient selection and tailored treatment are needed. Different prognostic factors linked with the patient, tumoral characteristics and treatment with curative intent have been identified and are the purpose of this review. Tumor detection at an earlier stage, the advent of new molecules and therapeutic combinations, and the centralization of management in high-volume centers should help to improve the prognosis of esophageal cancer. Improved imaging techniques and a better prediction strategy should guide future treatments.
Copyright © 2018 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chemoradiotherapy; Chemotherapy; Esophageal cancer; Prognosis; Surgery

Mesh:

Year:  2018        PMID: 30166221     DOI: 10.1016/j.dld.2018.08.002

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  8 in total

1.  Prognostic models for stage I-III esophageal cancer: a comparison between existing calculators.

Authors:  Riccardo Lemini; Tamara Díaz Vico; Denslow A Trumbull; Kristopher Attwood; Aaron C Spaulding; Enrique F Elli; Dorin T Colibaseanu; Moshim Kukar; Emmanuel Gabriel
Journal:  J Gastrointest Oncol       Date:  2021-10

2.  The effect of histologic grade on neoadjuvant treatment outcomes in esophageal cancer.

Authors:  David T Pointer; Jordan A McDonald; Samer A Naffouje; Rutika Mehta; Jason B Fleming; Jacques P Fontaine; Gregory Y Lauwers; Jessica M Frakes; Sarah E Hoffe; Jose M Pimiento
Journal:  J Surg Oncol       Date:  2022-05-16       Impact factor: 2.885

3.  Comprehensive Analysis of Tumor-Infiltrating Immune Cells and Relevant Therapeutic Strategy in Esophageal Cancer.

Authors:  Guangrong Lu; Liping Chen; Shengjie Wu; Yuao Feng; Tiesu Lin
Journal:  Dis Markers       Date:  2020-05-11       Impact factor: 3.434

4.  Identification and Validation of a Novel Genomic Instability-Associated Long Non-Coding RNA Prognostic Signature in Head and Neck Squamous Cell Carcinoma.

Authors:  Yun Chen; Yaqiong Zhao; Ruohuang Lu; Han Zhao; Yue Guo
Journal:  Front Cell Dev Biol       Date:  2022-01-20

5.  Prognostic variables for conditional survival in patients with esophageal squamous cell carcinoma who underwent minimally invasive surgery.

Authors:  Mingqiang Liang; Jiazhou Xiao; Maohui Chen; Bin Zheng; Chun Chen
Journal:  BMC Cancer       Date:  2022-03-26       Impact factor: 4.430

6.  Real-world experience with anti-programmed cell death protein 1 immunotherapy in patients with esophageal cancer: A retrospective single-center study.

Authors:  Xinpeng Wang; Lvjuan Cai; Mengjing Wu; Guo Li; Yunyun Zhu; Xinyue Lin; Xue Yan; Peng Mo; Huachun Luo; Zhichao Fu
Journal:  Front Oncol       Date:  2022-09-09       Impact factor: 5.738

7.  Tumor microenvironment characterization in esophageal cancer identifies prognostic relevant immune cell subtypes and gene signatures.

Authors:  Yuhong Zhang; Minqi Zhu; Junxian Mo; Lei Xian
Journal:  Aging (Albany NY)       Date:  2021-12-26       Impact factor: 5.682

8.  Esophageal Cancer Associated Immune Genes as Biomarkers for Predicting Outcome in Upper Gastrointestinal Tumors.

Authors:  Chuanhui Zhu; Qianqian Xia; Bin Gu; Mengjing Cui; Xing Zhang; Wenjing Yan; Dan Meng; Siyuan Shen; Shuqian Xie; Xueliang Li; Hua Jin; Shizhi Wang
Journal:  Front Genet       Date:  2021-07-19       Impact factor: 4.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.